item1
KCPrescriptionDrugLawyerBanner
KansasCitySuperLawyers1
advforum1a
prr1a
Lawsuits
KCLawyer
PHARMACEUTICAL LITIGATION >>
PrescriptionDrugLawsuits
NursingHomeNeglect
TruckingAccidentLawyer
MedicalDeviceLawsuit
PersonalInjuryAttorney
CarAccidentLawyer
877-378-4442
PetersonandAssociatesPC
PROTECTING YOU
HOME
KansasCityAttorneyPractice
AREAS OF PRACTICE
$350+ MILLION
PrescriptionDrugLawyer
PetersonFoundLogoFinalJS3a1a
®
ThePetersonFoundation1
LawyerBlog
LawFirmBlog
FIRM UPDATES
SUCCESS STORIES
THE BLOG
CONTACT US
AREAS OF PRACTICE
PracticeAreas3
VIDEOS
ABOUT OUR FIRM
SuperLawyer2010BackCoverFinal1
PrescriptionLawyer
PharmaceuticalLawsuit
Lawyer
LawyerforPrescriptionDrugs
ClassActionLawyer
FreeLegalHelp
LawyerHelp
million06
Lawsuit1
FREE  CASE EVALUATION
FreeLegalReview
CLIENT TESTIMONIALS

*Past results afford no guarantee of future results and each case is different and is judged on its own merits. Some cases result in no recovery. Costs and expenses will be advanced and reimbursed to us only if you recover. You have no liability for costs or expenses unless a court directs. The choice of a lawyer is an important decision and should not be based solely upon advertisements. Some matters may be referred to other lawyers. Neither the Supreme Court of Missouri nor the Missouri Bar reviews or approves certifying organizations or specialist designations. Never stop taking any prescription drug without first consulting with a doctor. Not available in all states.

View Our Full Disclaimer | Legal Resources

site map | contact us | about peterson law firm

© 2010 Peterson & Associates, P.C. – Kansas City Injury Lawyers / Missouri Accident Attorneys / Drug Recall Lawyer

FreeCaseWindow
ClicktoEmailKCLawyer
CLICK TO EMAIL
ClicktoCallKCLawyer1a
CLICK TO CALL
-
(
NAME :
PHONE NUMBER :
EMAIL (required) :
COMMENTS :
FREE CASE REVIEW
Security Question (required) :

Arava® Lawsuit | Arava Lawyer | Arava Death Risk

Manufacturer: Aventis Pharmaceutical
Uses: Treatment of Active Rheumatoid Arthritis

aravaAventis Pharmaceuticals and FDA updated the prescribing information for Arava (leflunomide), indicated for the treatment of active rheumatoid arthritis. In post marketing experience worldwide, rare, serious hepatic injury, including cases with fatal outcome, have been reported during the treatment with Arava. Most cases occurred within six months of therapy and in a setting of multiple risk factors for hepatoxicity. Rare post-marketing reports of severe infections, including sepsis, which may be fatal, were also received. Most of the reports were confounded by concomitant immunosuppressant therapy comorbid illness, which, in addition to rheumatoid disease, may predispose patients to infection.

So far, there have been at least 130 cases of severe liver problems (hepatoxicity) and 22 deaths since Arava's arrival to the market in 1998. Arava side effects can result in continued instances of death and serious health conditions that may have been prevented.

Get a FREE Legal Consultation about your Arava® case with a lawyer immediately!

5928
facebook
OUR ATTORNEYS
DepuyHipReplacementMillion $350+ MILLION PrescriptionLawyer PharmaceuticalLawsuit Lawyer LawyerforPrescriptionDrugs ClassActionLawyer FreeLegalHelp LawyerHelp million06 Lawsuit1 FreeLegalReview ClicktoEmailKCLawyer ClicktoCallKCLawyer1a